Form 4 for EVMN Evommune, Inc.
Accepted 2026-06-03 20:03:06 ET · period of report 2026-06-02 · accession 0001347383-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-03 20:03 | 2026-06-02 | EVMN | Cohen David E | Dir | S - Sale | $20.33 | -6,056 | 17.6K | -26% | -$123.1K |
| DT | 2026-06-03 20:03 | 2026-06-02 | EVMN | Cohen David E | Dir | A - Grant | $0.00 | +15.7K | 15.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | S | D | 5,456 | $20.21 | 18,209 | D | — | — | (F1) The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. (F2) The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $20.00 to $20.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2026-06-02 | S | D | 600 | $21.38 | 17,609 | D | — | — | (F1) The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. (F3) The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $21.06 to $21.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to buy) | 2026-06-02 | A | A | 15,673 | $0.00 | 15,673 | D | $19.82 · — to 2036-06-01 | 15,673 Common Stock | (F4) The shares subject to the option award shall vest at the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date. |